1. Home
  2. EVO vs BHE Comparison

EVO vs BHE Comparison

Compare EVO & BHE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • BHE
  • Stock Information
  • Founded
  • EVO 1993
  • BHE 1979
  • Country
  • EVO Germany
  • BHE United States
  • Employees
  • EVO N/A
  • BHE N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • BHE Electrical Products
  • Sector
  • EVO Health Care
  • BHE Technology
  • Exchange
  • EVO Nasdaq
  • BHE Nasdaq
  • Market Cap
  • EVO 1.5B
  • BHE 1.7B
  • IPO Year
  • EVO 2021
  • BHE 1990
  • Fundamental
  • Price
  • EVO $4.11
  • BHE $48.06
  • Analyst Decision
  • EVO Buy
  • BHE Strong Buy
  • Analyst Count
  • EVO 2
  • BHE 3
  • Target Price
  • EVO $5.90
  • BHE $42.33
  • AVG Volume (30 Days)
  • EVO 184.0K
  • BHE 252.7K
  • Earning Date
  • EVO 11-06-2024
  • BHE 01-29-2025
  • Dividend Yield
  • EVO N/A
  • BHE 1.39%
  • EPS Growth
  • EVO N/A
  • BHE N/A
  • EPS
  • EVO N/A
  • BHE 1.72
  • Revenue
  • EVO $866,665,179.00
  • BHE $2,690,572,000.00
  • Revenue This Year
  • EVO $3.89
  • BHE N/A
  • Revenue Next Year
  • EVO $9.65
  • BHE $4.51
  • P/E Ratio
  • EVO N/A
  • BHE $27.97
  • Revenue Growth
  • EVO N/A
  • BHE N/A
  • 52 Week Low
  • EVO $2.85
  • BHE $25.57
  • 52 Week High
  • EVO $8.39
  • BHE $52.57
  • Technical
  • Relative Strength Index (RSI)
  • EVO 42.87
  • BHE 58.97
  • Support Level
  • EVO $4.00
  • BHE $44.18
  • Resistance Level
  • EVO $4.63
  • BHE $48.12
  • Average True Range (ATR)
  • EVO 0.14
  • BHE 1.11
  • MACD
  • EVO -0.04
  • BHE 0.27
  • Stochastic Oscillator
  • EVO 16.88
  • BHE 97.00

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About BHE Benchmark Electronics Inc.

Benchmark Electronics Inc is engaged in product designing, engineering services, technology solutions, and advanced manufacturing services (electronic manufacturing services (EMS) and precision technology services). It serves various industries, including aerospace & defense (A&D), medical technologies, complex industrials, semiconductor capital equipment, next-generation telecommunications, and high-end computing. Its geographical segments are the Americas, Asia and Europe of which key revenue is derived from the Americas.

Share on Social Networks: